These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8188460)

  • 1. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
    Pepose JS; Leib DA
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
    [No Abstract]   [Full Text] [Related]  

  • 2. Replication-defective genomic herpes simplex vectors: design and production.
    Burton EA; Bai Q; Goins WF; Glorioso JC
    Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of replication-competent and -defective HSV vectors.
    Goins WF; Krisky DM; Wechuck JB; Wolfe D; Huang S; Glorioso JC
    Cold Spring Harb Protoc; 2011 May; 2011(5):pdb.prot5615. PubMed ID: 21536761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery to neurons: is herpes simplex virus the right tool for the job?
    Leib DA; Olivo PD
    Bioessays; 1993 Aug; 15(8):547-54. PubMed ID: 8135768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
    Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of multiply disabled herpes simplex viral vectors for gene delivery to the nervous system.
    Lilley CE; Coffin RS
    Methods Mol Med; 2003; 76():33-49. PubMed ID: 12526157
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and application of herpes simplex virus vectors for human gene therapy.
    Glorioso JC; DeLuca NA; Fink DJ
    Annu Rev Microbiol; 1995; 49():675-710. PubMed ID: 8561476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of replication-defective herpes simplex virus vectors.
    Goins WF; Marconi P; Krisky D; Wolfe D; Glorioso JC; Ramakrishnan R; Fink DJ
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.11. PubMed ID: 18428322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered herpes simplex viral vectors in the treatment of brain tumors: a review.
    Aghi M; Chiocca EA
    Cancer Invest; 2003 Apr; 21(2):278-92. PubMed ID: 12743992
    [No Abstract]   [Full Text] [Related]  

  • 11. Herpes simplex virus type 1-based amplicon vector systems.
    Fraefel C; Jacoby DR; Breakefield XO
    Adv Virus Res; 2000; 55():425-51. PubMed ID: 11050950
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene transfer to neurons using herpes simplex virus-based vectors.
    Fink DJ; DeLuca NA; Goins WF; Glorioso JC
    Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular gene therapy: experimental studies and clinical possibilities.
    Murata T; Kimura H; Sakamoto T; Osusky R; Spee C; Stout TJ; Hinton DR; Ryan SJ
    Ophthalmic Res; 1997; 29(5):242-51. PubMed ID: 9323715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ocular disorders by gene therapy.
    Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the herpes simplex viral genome to construct gene therapy vectors.
    Burton EA; Huang S; Goins WF; Glorioso JC
    Methods Mol Med; 2003; 76():1-31. PubMed ID: 12526156
    [No Abstract]   [Full Text] [Related]  

  • 16. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
    Fraefel C; Marconi P; Epstein AL
    Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-50/GAP-43 expression via a defective herpes simplex virus vector results in persistent morphological changes in non-neuronal cells.
    Verhaagen J; Hermens WT; Kaplitt MG; Pfaff DW; Gispen WH
    Gene Ther; 1994; 1 Suppl 1():S81. PubMed ID: 8542427
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex amplicon vectors.
    Link CJ; Vahanian NN; Wang S
    Methods Mol Med; 2003; 76():61-87. PubMed ID: 12526159
    [No Abstract]   [Full Text] [Related]  

  • 19. No false start for novel pseudotyped vectors.
    Sanders DA
    Curr Opin Biotechnol; 2002 Oct; 13(5):437-42. PubMed ID: 12459334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
    Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
    Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.